Terms: = Uterine cancer AND LEF1, TCF1ALPHA, 51176, ENSG00000138795, Q9UJU2, DKFZp586H0919
17 results:
1. Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis.
Brown M; Leon A; Kedzierska K; Moore C; Belnoue-Davis HL; Flach S; Lydon JP; DeMayo FJ; Lewis A; Bosse T; Tomlinson I; Church DN
EMBO Mol Med; 2023 Oct; 15(10):e17094. PubMed ID: 37589076
[TBL] [Abstract] [Full Text] [Related]
2. A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer.
He WP; Chen YY; Wu LX; Guo YY; You ZS; Yang GF
Front Immunol; 2022; 13():1018544. PubMed ID: 36466815
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma.
Ruz-Caracuel I; López-Janeiro Á; Heredia-Soto V; Ramón-Patino JL; Yébenes L; Berjón A; Hernández A; Gallego A; Ruiz P; Redondo A; Peláez-García A; Mendiola M; Hardisson D
Virchows Arch; 2021 Dec; 479(6):1167-1176. PubMed ID: 34420090
[TBL] [Abstract] [Full Text] [Related]
4. Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial cancer.
Wu X; Han Y; Liu F; Ruan L
J Comput Biol; 2020 May; 27(5):834-844. PubMed ID: 31513434
[TBL] [Abstract] [Full Text] [Related]
5. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
[TBL] [Abstract] [Full Text] [Related]
6. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
7. Gene expression profiling of low-grade endometrial stromal sarcoma indicates fusion protein-mediated activation of the Wnt signaling pathway.
Przybyl J; Kidzinski L; Hastie T; Debiec-Rychter M; Nusse R; van de Rijn M
Gynecol Oncol; 2018 May; 149(2):388-393. PubMed ID: 29544705
[TBL] [Abstract] [Full Text] [Related]
8. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
He S; Liao B; Deng Y; Su C; Tuo J; Liu J; Yao S; Xu L
BMC Cancer; 2017 Oct; 17(1):673. PubMed ID: 28978307
[TBL] [Abstract] [Full Text] [Related]
9. lef1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions.
Schmoeckel E; Odai-Afotey AA; Schleißheimer M; Rottmann M; Flesken-Nikitin A; Ellenson LH; Kirchner T; Mayr D; Nikitin AY
Mod Pathol; 2017 Sep; 30(9):1241-1250. PubMed ID: 28664938
[TBL] [Abstract] [Full Text] [Related]
10. EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial cancer Cells That Promote Epithelial-to-Mesenchymal Transition.
Hsu YT; Osmulski P; Wang Y; Huang YW; Liu L; Ruan J; Jin VX; Kirma NB; Gaczynska ME; Huang TH
Cancer Res; 2016 Nov; 76(21):6171-6182. PubMed ID: 27569206
[TBL] [Abstract] [Full Text] [Related]
11. Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer.
Crum CP; Herfs M; Ning G; Bijron JG; Howitt BE; Jimenez CA; Hanamornroongruang S; McKeon FD; Xian W
J Pathol; 2013 Dec; 231(4):402-12. PubMed ID: 24030860
[TBL] [Abstract] [Full Text] [Related]
12. The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells.
Kusunoki S; Kato K; Tabu K; Inagaki T; Okabe H; Kaneda H; Suga S; Terao Y; Taga T; Takeda S
Gynecol Oncol; 2013 Jun; 129(3):598-605. PubMed ID: 23500085
[TBL] [Abstract] [Full Text] [Related]
13. The role of lef1 in endometrial gland formation and carcinogenesis.
Shelton DN; Fornalik H; Neff T; Park SY; Bender D; DeGeest K; Liu X; Xie W; Meyerholz DK; Engelhardt JF; Goodheart MJ
PLoS One; 2012; 7(7):e40312. PubMed ID: 22792274
[TBL] [Abstract] [Full Text] [Related]
14. L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions.
Pfeifer M; Schirmer U; Geismann C; Schäfer H; Sebens S; Altevogt P
BMC Mol Biol; 2010 Aug; 11():64. PubMed ID: 20799950
[TBL] [Abstract] [Full Text] [Related]
15. Simultaneous immunohistochemical localization of beta-catenin and cyclin D1 in differentiated but not in undifferentiated human endometrial carcinoma.
Narita F; Sato A; Hamana S; Deguchi M; Otani T; Maruo T
Eur J Gynaecol Oncol; 2003; 24(2):129-34. PubMed ID: 12701961
[TBL] [Abstract] [Full Text] [Related]
16. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas.
Ueda M; Gemmill RM; West J; Winn R; Sugita M; Tanaka N; Ueki M; Drabkin HA
Br J Cancer; 2001 Jul; 85(1):64-8. PubMed ID: 11437403
[TBL] [Abstract] [Full Text] [Related]
17. Beta-catenin mutation in carcinoma of the uterine endometrium.
Fukuchi T; Sakamoto M; Tsuda H; Maruyama K; Nozawa S; Hirohashi S
Cancer Res; 1998 Aug; 58(16):3526-8. PubMed ID: 9721853
[TBL] [Abstract] [Full Text] [Related]
